| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.8M | — | -0.8% |
| Cost of Revenue | $7.1M | — | +3.2% |
| Gross Profit | $4.7M | — | -6.2% |
| R&D Expense | $905K | — | +3.3% |
| SG&A Expense | $1.6M | — | -16.0% |
| Operating Income | -$324K | — | -58.0% |
| Pre-tax Income | -$466K | — | +72.2% |
| Income Tax | $58K | — | +383.3% |
| Net Income | -$524K | — | +68.9% |
| EPS (Basic) | -$0.03 | — | +70.0% |
| EPS (Diluted) | -$0.03 | — | +70.0% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.6M | -23.8% | -36.6% |
| Accounts Receivable | $6.8M | -10.1% | +2.5% |
| Inventory | $9.3M | +18.4% | -8.1% |
| Current Assets | $24.6M | -2.6% | -15.6% |
| Total Assets | $28.3M | -3.0% | -17.4% |
| Current Liabilities | $12.8M | -2.9% |
| Line Item | 2026-04-04 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | -16.2% |
| Capital Expenditures | $101K | — | +818.2% |
| Investing Cash Flow | -$101K | — | -818.2% |
| Financing Cash Flow | -$1K | — | -100.0% |
| Free Cash Flow | -$1.4M | — | -23.8% |
| -14.2% |
| Total Liabilities | $23.5M | -2.8% | -14.0% |
| Stockholders' Equity | $4.7M | -3.9% | +455.4% |